ATP Innovations opens applications for the NSW Medical Device Commercialisation Training Program (MDCTP)
Australia’s leading advanced technology incubator ATP Innovations is proud to be delivering the new expanded Medical Device Commercialisation Training Program (MDCTP). The program offers an invaluable opportunity for NSW-based medical device researchers and clinicians.
Yesterday, Monday 10th October, the NSW Minister for Health the Hon. Jillian Skinner confirmed further support and funding for the MDCTP. The announcement was made during the 2016 Medical Devices Fund (MDF) grant awards night at NSW Parliament House, where three alumni of the MDCTP received MDF grants.
First run in 2014, ATP Innovations delivers the MDCTP with the support and funding from the NSW Office for Health and Medical Research. The program will provide learning opportunities for up to 200 NSW-based medical device researchers and clinicians each year over the next 4 years.
NSW leads Australia in medical device research excellence and IP registration, yet commercialisation remains low by OECD standards. Commercialising this research so that it is accessible to the public and creates impact requires long-term investment. But it needs the development of skills in our researchers that allow them to take their innovation to market. The MDCTP, championed by Minister Skinner, is changing that dynamic. The results so far have been outstanding.
Graduates of MDCTP have launched companies, engaged industry partners and raised more than $13 million in grants and private investment, creating job opportunities in Australia and abroad.
The program has been particularly successful at encouraging women as entrepreneurs; last year’s top candidate, Professor Stephanie Watson, was awarded $50,000 in seed funding for her start-up Ocurep, which is developing a sutureless wound-sealing device for cataract surgery. Ocurep went on to raise a further $1.3 million from the NSW Medical Devices Fund.
Dr Ilana Feain, founder of Nano-X, won a number of start-up innovation awards and secured $2.6 million from the MDF to commercialise a novel cost-effective cancer therapy system.
Dr Dharmica Mistry, chief scientist and co-founder at BCAL Diagnostics, was named NSW Young Woman of the Year for 2016 for her work developing a blood test to detect breast cancer.
Skills developed during the program include IP management, business model development, customer engagement, medical device design and prototyping, and regulatory affairs management.
NSW-based postgraduate researchers, clinicians and PhD candidates completing their degree this year are encouraged to apply. Applicants must have a demonstrated interest in medical device innovation and commercialisation. For information about course eligibility and content, please visit ATP Innovations website < http://atp-innovations.com.au/mdctp/>.
Applications open – 11 October 2016
Applications close – 28 November 2016
Shortlist interviews – week of 5 December 2016
Ignition IP course – 21 November 2016 (1 day)
Ignition CORE course – 1 February 2017 (for 12 weeks)
Program information sessions on 24 October and 14 November at ATP Innovations. Visit ATP Innovations website for more details and to apply http://atp-innovations.com.au/mdctp/.
About ATP Innovations
ATP Innovations is Australia’s leading incubator for advanced technology startups. The incubator is internationally recognised and jointly owned by four of Australia’s leading universities: Australian National University, University of New South Wales, University of Technology Sydney and University of Sydney.
ATP Innovations partners with technical founders to help them accelerate and achieve global commercial success. Its portfolio currently has more than 70 companies across life sciences, hardware and enterprise software technology sectors. In the past 12 months ATP Innovations has helped its portfolio of companies raise $79 million in public and private funding.
Program Enquiries contact at ATP Innovations
02 9209 4444
Media contact at ATP Innovations
0403 723 215
02 9209 4444